ICH GMP and Swissmedic market authorization.

Since 1990, the global harmonisation of regulatory requirements for pharmaceuticals has been led by the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Linnea is absolutely committed to conforming with these standards such that the Linnea name remains a guarantee of the highest purity, efficacy, and safety. Marketing authorization for active pharmaceutical ingredient and compliance with ICH standards is certified by Swissmedic (Swiss Health Authority).

In keeping with ICH standards, Linnea's in-house Quality Assurance systems and high standards of operation ensure consistency from batch to batch. And all of Linnea's manufacturing processes are fully validated and backed by comprehensive record-keeping and full batch traceability.